![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 18, 13888-13894, May 5, 2000
,From the Edinburgh Centre for Protein Technology, Department of Chemistry, Joseph Black Building, the University of Edinburgh, The King's Buildings, West Mains Road, Edinburgh EH9 3JJ, Scotland, United Kingdom
| |
ABSTRACT |
|---|
|
|
|---|
The gene encoding Escherichia coli
biotin synthase (bioB) has been expressed as a histidine
fusion protein, and the protein was purified in a single step using
immobilized metal affinity chromatography. The His6-tagged
protein was fully functional in in vitro and in
vivo biotin production assays. Analysis of all the published
bioB sequences identified a number of conserved residues.
Single point mutations, to either serine or threonine, were carried out
on the four conserved (Cys-53, Cys-57, Cys-60, and Cys-188) and one
non-conserved (Cys-288) cysteine residues, and the purified mutant
proteins were tested both for ability to reconstitute the [2Fe-2S]
clusters of the native (oxidized) dimer and enzymatic activity. The
C188S mutant was insoluble. The wild-type and four of the mutant
proteins were characterized by UV-visible spectroscopy, metal and
sulfide analysis, and both in vitro and in vivo
biotin production assays. The molecular masses of all proteins were
verified using electrospray mass spectrometry. The results indicate
that the His6 tag and the C288T mutation have no effect on
the activity of biotin synthase when compared with the wild-type
protein. The C53S, C57S, and C60S mutant proteins, both as prepared and
reconstituted, were unable to covert dethiobiotin to biotin in
vitro and in vivo. We conclude that three of the conserved cysteine residues (Cys-53, Cys-57, and Cys-60), all of which
lie in the highly conserved "cysteine box" motif, are crucial for
[Fe-S] cluster binding, whereas Cys-188 plays a hitherto unknown
structural role in biotin synthase.
The biotin operon of Escherichia coli contains six open
reading frames that encode at least four of the proteins essential for
the conversion of pimeloyl-CoA to biotin (1). The recent determination
of the structure of three of these enzymes, 8-amino-7-oxononanoate synthase (2), 7,8-diaminononanoate synthase (3), and dethiobiotin synthase (4), encoded by the bioF, bioA, and
bioD genes respectively, has shed light on the mechanism of
the steps involved in the conversion of alanine to dethiobiotin.
However, the mechanism of the final step, the conversion of
dethiobiotin to biotin catalyzed by biotin synthase (see Scheme
1), remains unresolved.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
View larger version (6K):
[in a new window]
Scheme 1.
Numerous studies have shown that a fully functional in vitro
system for conversion of dethiobiotin to biotin requires not only the
product of the bioB gene but also several other proteins and
low molecular weight molecules. Although the exact components of this
system vary between different laboratories,
S-adenosylmethionine (AdoMet),1 NADPH, cysteine,
DTT, Fe2+, and a reducing system (5) are common to all. The
reducing system we and others use consists of flavodoxin (FLD) (6) and flavodoxin (ferredoxin) NADP+ oxidoreductase (FLDR) (7)
(which we believe to be the physiological system) which Marquet and
co-workers (8) have found can be replaced by a photoreduced
deazaflavin. Both systems appear to be equally effective in providing
reducing equivalents for the reaction. There is, however, conflicting
evidence that other proteins, cofactors, and allosteric activators may
also be required for competence of the biotin synthase complex. There
is no doubt that addition of extracts derived from E. coli
bioB
strains can enhance activity of biotin
synthase, but whether this is due to the presence of a thiamine
pyrophosphate-stabilized protein (7), high levels of constitutive low
molecular weight cellular components such as fructose 1,6-biphosphate
and the labile (and as yet uncharacterized) AdoMet-derived product of
the 7,8-diaminononanoate synthase reaction (5), or indeed to a
combination of several of these factors is still open to question.
Recent results indicate that the sulfur incorporated in the tetrahydrothiophene ring of biotin is ultimately derived from cysteine (7) and that 9-mercaptodethiobiotin (but not 6-mercaptodethiobiotin) can act as an intermediate (9). The intermediacy of 9-mercaptodethiobiotin, racemization at C-9 (10) (but not at C-6 (11)), and the requirement for at least two molecules of AdoMet for each ring formation step provides clues to the mechanism of C-S bond formation (12). Taken together these results suggest that the mechanism involves the following: (a) initial AdoMet-dependent radical formation at C-9; (b) capture of sulfur by the C-9 radical to form a 9-mercaptodethiobiotin derivative; and (c) a second AdoMet-initiated radical formation by abstraction of the pro-S hydrogen at C-6 to generate a conformationally restrained radical that subsequently captures the C-9 thiol resulting in tetrahydrothiophene ring closure (13). Recent studies indicate that a sulfur atom of the [Fe-S] cluster of biotin synthase, rather than cysteine itself, may act as the actual sulfur donor, suggesting that the [Fe-S] cluster of the enzyme must be regenerated prior to the next reaction (14). Thus biotin synthase could be regarded as both a reagent and a catalyst. It has been suggested that a NifS-like enzyme, similar to the Azotobacter vinelandii NifS (15), may be required for construction of the [Fe-S] cluster in vivo and regeneration in vitro but such an activity has still to be identified. NifS is a pyridoxal phosphate-dependent enzyme that catalyzes the desulfuration of L-cysteine to yield L-alanine and sulfide that has been shown to catalyze [Fe-S] cluster formation in vitro and in vivo.
The fact that E. coli biotin synthase is based on a core [2Fe-2S] protein with a requirement for a FLD/FLDR redox couple and AdoMet as a radical generator suggests that it belongs to the family of enzymes that include anaerobic ribonucleotide reductase-activating enzyme (ARR-AE) (16), pyruvate formate-lyase-activating enzyme (PFL-AE) (17), lysine 2,3-aminomutase (LAM) (18), and lipoic acid synthase (LIPA) (19). Even within this small group there already appears to be differences with regard to subunit composition and chemical function; biotin synthase, LIPA, and ARR-AE are dimers; LAM is a hexamer, and PFL-AE is a monomer. Biotin synthase, LIPA, and LAM generate a radical on a small molecule, whereas ARR-AE and PFL-AE generate a protein glycyl radical.
Characterization of the E. coli biotin synthase has been complicated by the fact that most preparations of the protein contain variable amounts of polymeric forms (mainly dimers and tetramers) with variable [Fe-S] content. The major native form of the core biotin synthase, however, appears to be a 76-kDa dimer, each monomer containing an [2Fe-2S] cluster (20). Spectroscopic studies suggest that reduction of the two [2Fe-2S] clusters in the oxidized protein dimer, an obligatory step in the mechanism, results in formation of a biotin synthase dimer containing a single [4Fe-4S] cluster in which each of the iron centers is coordinated to a thiol ligand(s) of the protein (21-23).
However, almost nothing is known about the protein residues involved in
coordination to the [Fe-S] clusters of biotin synthase. Whereas the
active sites have been proposed to involve the cysteine thiols of the
common GXCXXXCXXCXQ motif
as a "cysteine ([Fe-S] coordination) box" motif, there has been
as yet no experimental evidence to support this contention (20). In
this paper we describe studies on mutants of the biotin synthase
protein that uniquely identify the key protein cysteine residues
involved in formation of the [Fe-S] cluster.
| |
EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
Materials-- Electrophoresis was carried out using a Bio-Rad Protean II minigel system (protein) and a Life Technologies, Inc., H5 system (DNA). PCR and sequencing reactions were done on a Perkin-Elmer 480 thermal cycler, and automated DNA sequencing was carried out using an ABI prism 377 DNA sequencer. An Amersham Pharmacia Biotech FPLC system and columns were used for chromatographic separations of proteins. Electrospray mass spectrometry was performed on a Micromass Platform II quadrupole mass spectrometer. UV-visible spectrophotometry was done on a Unicam UV4. Determination of metal ion concentrations were carried out using a Thermo Jarrell Ash IRIS inductively coupled plasma atomic emission spectrometer. Primers were purchased from Life Technologies, Inc., and Ready to Go PCRTM beads from Amersham Pharmacia Biotech. Pre-cast SDS-PAGE gels (10% Bis-Tris) were purchased from Novex and were used according to the manufacturer's instructions.
E. coli Strains and Plasmids--
The E. coli strain
Top 10 One ShotTM cells (F'mcrA
D(mrr-hsdRMS-mcrBC) F80lacZDM15
DlacX74 deoR recA1 araD139
(ara-leu)7697 galU galK
rpsL endA1 nupG, Invitrogen) were used
for the maintenance of plasmids and also for the initial transformation
of ligation products. HMS174 (DE3) cells (F-
recA
hsdR(rK12
mK12+)
Rifr (DE3), Novagen) were used for the overexpression of
genes cloned into pET plasmids. PCOi (bio
(att
, bio uvrB) thr, leu, thi, placi) was used
to prepare a biotin minus cell-free extract. The biotin auxotroph
Lactobacillus plantarum (ATCC 8014) was used in the
microbial biotin assay (24). A 1041-base pair
NcoI/BamHI fragment from pB030 (a gift from Lonza AG) containing the bioB gene was cloned into the same sites
of pET16b (Novagen), and the resultant plasmid was called
pET16b/bioB.
Mutagenesis-- Site-directed mutagenesis was performed using the "mega-primer" PCR method using vector forward (BIOB PCR) and reverse (M13) oligonucleotides and the mutagenic primers (C53S, C57S, C60S, C188S and C288T) (25). The typical PCR reaction volume was 50 µl and consisted of template DNA (1 µl), forward primer (1 µM), reverse primer (1 µM), water (39 µl), and two Taq beads. The primers for the cysteine mutations used were C53S (5' AAG ACC GGA GCT TCC CCG GAA GAT 3'), C57S (5' CCG GAA GAT TCT AAA TAC TGC CCG 3'), C60S (5' AAA TAC TCT CCG CAA ACG TCG CGC 3'), C188S (5' GGG ATC AAA GTC TCT TCT GGC 3'), and C288T (5' GGT CAG CAG TTT GGT ACC GTA 3'). The bases underlined in each primer indicate the position where the cysteine codon is replaced by one encoding a serine or in the case of C288T a threonine. The bases in bold indicate a KpnI restriction site. All clones were sequenced, and the data were analyzed using ABI Prism editview software.
Preparation of Biotin Synthase Cell-free Extracts--
Wild-type
biotin synthase, His6-tagged biotin synthase (from HMS174
(DE3)/pET16b/bioB and pET6H/bioB), and mutant proteins (from HMS174
(DE3)/pHC53S, pHC57S, pHC60S, pHC188S, and pHC288T) were prepared from
cultures grown in 2-10 liters of 2YT media (tryptone (16 g/liter),
yeast extract (10 g/liter), sodium chloride (5 g/liter), pH 7.5)
containing ampicillin (100 µg/ml). Transformed cells were grown at
37 °C (shaking 250 rpm) until the A600 nm = 1.0 and biotin synthase was produced by addition of IPTG to a final
concentration of 1 mM. Cells (~2.5 g/liter wet weight) were harvested (5,000 × g for 20 min, 4 °C) after a
further 4 h of growth. The cells pellets were washed by
resuspension in ice-cold buffer A (20 mM Tris-HCl, pH 7.9, 0.5 M sodium chloride, 5 mM imidazole). All
other cell pellets were washed in buffer B (100 mM sodium
phosphate, pH 7.5). The cell pellets were lysed by intermittent
sonication (30 s on, 30 s off) 4 °C for 15 min. Cellular debris
was removed by centrifugation (15,000 × g for 30 min,
4 °C), and the supernatants were stored frozen (
20 °C) in
glycerol (15%). The PCOi (bioB
) strain was
grown in 2YT, and the cells washed with buffer A and cell extracts,
used for augmentation in the in vitro assay, were prepared
in a similar fashion to that described above.
Purification of Wild-type Biotin Synthase--
Protamine sulfate
(1%, 0.5 ml per 10 ml) was added to the cell-free extract to remove
nucleic acids. After ammonium sulfate (45%) precipitation,
precipitated proteins were collected by centrifugation, resuspended in
buffer B, and filtered (0.45 µm) prior to being loaded onto a
Q-Sepharose 26/10 high load anion exchange column (2.5 × 10 cm)
which had been equilibrated with buffer B. The proteins were eluted
with an increasing gradient of potassium chloride (0-1 M, 20 CV) in
buffer B. The deep red fractions containing biotin synthase eluted at
300 mM salt. These were combined, brought to a final
concentration of 10% ammonium sulfate, and loaded onto a
phenyl-Sepharose hydrophobic interaction column (1 × 30 cm) that
had been equilibrated with buffer B containing ammonium sulfate (10%).
Biotin synthase was eluted with a decreasing gradient of buffer B
containing ammonium sulfate (10-0%, 20 CV). Biotin synthase eluted at
the end of the gradient, and these fractions were combined and
filtration concentrated (Amicon PM10 membrane). The protein was
purified by gel filtration on Sephacryl S-200 HR eluting with buffer B. Protein samples were diluted with glycerol (15%) and stored
(
80 °C).
Purification of His6-tagged Biotin Synthase and
Mutants--
Cell-free extracts were loaded directly onto a
Hi-TrapTM-chelating column (5 ml, Amersham Pharmacia
Biotech) that had been charged with NiSO4 (100 mM) and prewashed with buffer A. Proteins were eluted with
a linear gradient of (5 mM to 1 M) imidazole in
buffer A. Biotin synthase-containing fractions typically eluted between 120 and 150 mM imidazole. These were combined and
exhaustively dialyzed against buffer B to remove imidazole and nickel
salts and concentrated by ultrafiltration. The purity and integrity of
wild-type, His6-tagged, and mutant biotin synthase forms
were assessed by SDS-PAGE, mass spectrometry, and UV-visible
spectrophotometry. Protein concentrations were determined by the
Bradford method using bovine serum albumin as a reference (26) and by
spectrophotometry using reported extinction coefficients
(
274 nm = 3.3 × 104
M
1 cm
1,
330 nm = 1.4 × 104 M
1
cm
1,
420 nm = 6.0 × 103
M
1 cm
1,
453 nm = 7.1 × 103 M
1
cm
1,
540 nm = 3.5 × 103
M
1 cm
1) (20).
Mass Spectrometry-- Prior to mass spectrometry all protein samples were passed through an Aquapure reverse phase C-4 column at a constant trifluoroacetic acid concentration of 0.1% using a linear gradient of 10-100% acetonitrile in water over 40 min at a flow rate of 1 ml/min and the separation monitored at 280 nm. The total ion count of all the ions in the m/z range 500-2,000 was recorded. The mass spectrometer was scanned at intervals of 0.1 s, the scans accumulated, spectra combined, and the average molecular mass determined using MaxEnt and Transform algorithms of MassLynx software.
Sequence Alignments-- Swiss-Prot and the Genomes Representation Organization data bases were used to search for amino acid sequences that were then aligned using Expasy, Clustal W, and Alscript (27).
Preparation of Apo and Holo Wild-type Biotin Synthase and Mutants-- This was carried out using methods previously described (14, 20).
In Vitro Assay for Biotin Synthase Activity-- In vitrobiotin production was determined using the Lactobacillus assay (24). Incubations were carried out both aerobically and anaerobically in buffer B. A typical assay mixture contained biotin synthase or mutant protein (5 µM), potassium chloride (10 mM), dethiobiotin (50 µM), AdoMet (150 µM), Fe(NH4)2(SO4)2 (5 mM), NADPH (1 mM), fructose 1,6-biphosphate (5 mM), L-cysteine (500 µM), DTT (10 mM), PCOi cell-free extract (100 µl), FLD (12.5 µM), and FLDR (2 µM). The final reaction volume was typically 1 ml. The reaction was incubated at 37 °C for 2 h and then stopped by adding 100 µl of 10% trichloroacetic acid. The resulting precipitate was centrifuged, and 5 µl of the supernatant was used for bioassay.
In Vivo Assays for Biotin Synthase Activity-- Transformants of HMS174 (DE3) with pET16b, pET6H, pET16b/bioB, pET6H/bioB, pHC53S, pHC57S, pHC60S, pHC188S, and pHC288T were grown in M9CA media containing dethiobiotin (5 µg/ml), glucose (0.4%), thiamine (0.8 µg/ml), MgSO4 (2 mM), CaCl2 (0.1 mM), and ampicillin (100 µg/ml). At A600 nm = 1.0 the cells were equally divided, and one sample was kept as a control and the other was induced with IPTG (1 mM). Aliquots (1 ml) of cells were removed from both control and induced samples at various time intervals. The cells were pelleted by centrifugation, and 5 µl of the supernatants were used in the bioassay as above. Supernatant from HMS174 (DE3) cells were grown in the same media minus ampicillin and used as the control.
Elemental Analyses--
Inductively coupled plasma atomic
emission spectroscopy (ICP-AES) was used for metal analyses. All data
were interpreted using thermospec/CID software. The radiofrequency
power was 1150 watts, the nebulizer flow was 30 pounds/square inch, the
pump rate was 100 rpm, and the purge time was 90 s.
Fe(NO3)3 (0.01-100 ppm; 180 nM
to 1.8 mM) and Ni(NO3)2
(0.0001-1.0 ppm; 1.7 nM to 17 mM) solutions
were used as standards. All biotin synthase samples (27 µM) and standard solutions were made up in buffer B (28). Chemical analysis for iron was carried out using the ferrozine assay as
described by Stookey (29) using the standard described above. Labile
sulfide analysis was determined as previously reported (20).
| |
RESULTS |
|---|
|
|
|---|
Overexpression of Biotin Synthase-- To study the molecular properties of wild-type and mutant forms of biotin synthase, we overproduced the protein using the pET system. In our hands we found the purification procedure described by Sanyal et al. (20) both technically difficult and time-consuming, although the procedure provided ~80% pure biotin synthase. We found it impossible to reproduce the purification of biotin synthase using a cobalt column, as described by Marquet and co-workers (30). To overcome these problems, we decided to express the protein with an N-terminal polyhistidine tag. The bioB gene was cloned into pET6H which fused the 5' terminus of the gene to a sequence encoding a MHHHHHHA tag. Overexpression of His6-tagged biotin synthase was carried out in HMS174 (DE3) and gave comparable expression levels when compared with wild-type biotin synthase. Optimal yields of both proteins were obtained by aerobic cell growth in 2YT at 37 °C. By using the IMAC purification system, we were able to routinely prepare 100-mg quantities of >95% pure His6-tagged biotin synthase from 5 liters of transformed cell culture.
Essential Cysteine Residues of Biotin Synthase--
Spectroscopic
studies on biotin synthase, PFL activase, and LIPA (17, 19, 31) suggest
that three cysteine residues from each monomer are required to
coordinate the iron in the [2Fe-2S] clusters of the oxidized dimer
and that two of these are required ligands in the reduced catalytically
active form. Five cysteine residues of biotin synthase (Cys-53, Cys-57,
Cys-60, Cys-188, and Cys-288) were replaced separately with serine or
threonine residues by site-directed mutagenesis (threonine was chosen
as a replacement for Cys-288 since it enabled us to engineer a
KpnI restriction site into the bioB gene to
facilitate mutant selection). Each of the mutant proteins was
overproduced in E. coli HMS174 (DE3), and its catalytic
activity was determined. Since the His6-tagged biotin
synthase showed identical in vitro spectroscopic parameters and catalytic activity to wild-type protein, the mutant bioB
genes were also expressed as histidine fusion proteins. Each of the mutant proteins was purified using IMAC under identical conditions to
the histidine-tagged wild-type biotin synthase except for mutant C188S,
which despite numerous attempts (low temperature induction and IPTG
concentrations <0.1 mM), remained intractably insoluble. Protein purity was estimated by SDS-PAGE (Fig.
1).
|
Preparation of Wild-type and His6-tagged Apoenzymes and the Reconstitution of [2Fe-2S] Cluster Containing Holoenzymes-- The apoenzymes of each of wild-type biotin synthase, His6-tagged biotin synthase, and mutants were prepared anaerobically using sodium dithionite and EDTA. The samples were then desalted using a G10 gel filtration column. ICP-AES analysis and UV-visible spectroscopy confirmed the absence of iron in the proteins. The samples were then reconstituted by incubation with FeCl3 and Na2S under similar conditions to those described previously (14, 20).
Spectral Characteristics--
Solutions of wild-type,
His6-tagged, and C288T biotin synthase were all reddish
brown in color, and they showed virtually identical UV-visible spectra
with a maximum at 274 nm, a shoulder at 330 nm, and a distinctive peak
at 420 nm (see Fig. 2). The spectra of
the apo forms of each of these proteins were colorless and showed no
peaks at 330 or 420 nm. Upon incubation with FeCl3 and
Na2S for 2 h, their spectra were identical to that of
the wild-type isolate.
|
The mutants (C53S, C57S, and C60S) were colorless, and their spectra showed no peaks indicative of the presence of an [Fe-S] cluster. Moreover, their spectra did not show any significant changes even after prolonged incubation with FeCl3 and Na2S.
All the mass spectrometry results were within 0.1% of the expected values for the polypeptide chains (Table I) indicating that the [Fe-S] cluster is lost under the MS conditions.
|
Elemental Analyses-- Analyses for iron, sulfur, and nickel were carried out on all proteins using ICP-AES, the Beinert method, and the ferrozine method (29). The protein concentrations were adjusted to ~27 µM (based on a monomeric mass of 39,673 Da for His6-tagged proteins and 38,648 Da for wild-type biotin synthase). The amount of sulfur (as S2-) in His6-tagged biotin synthase was virtually identical to that in the untagged protein and similar to the value previously reported by Sanyal et al. (20) for wild type. Analysis for nickel content proved that there was negligible nickel binding. Iron analysis (Table II) on the purified proteins revealed a 1:1 ratio between iron and sulfide in both unmodified and His6-tagged biotin synthase in agreement with previously reported values (14), although it should be noted that Sanyal (20) has reported a 2:1 ratio. In order to try to increase the iron/protein ratio, the proteins were converted to their apoenzymes by incubation with sodium dithionite and EDTA, and the [Fe-S] clusters were reconstituted by incubation with FeCl3 and Na2S. In the case of the wild-type, the His6-tagged, and C288T proteins, the protein/iron ratios increased to values comparable with those previously reported (20). The ferrozine assay gave a slightly lower iron/protein ratio than that obtained by ICP-AES (Table III).
|
|
In Vitro Assay for Biotin Production-- The in vitro activities of all proteins were determined using the Lactobacillus assay. Biotin was produced by the wild-type, the His6-tagged, and the C288T mutant but not by the three other cysteine mutants (Table IV). There was no difference in biotin production between aerobic and anaerobic incubations.
|
In Vivo Assay for Biotin Production-- HMS174 (DE3) cells did not produce detectable levels of biotin either on their own or when transformed with pET16b and pET6H and were used as a control. To examine whether or not the His6 tag affected biotin synthase activity, an in vivo assay was carried out using HMS174 (DE3) cells transformed with either pET16b/BioB or pET6H/bioB. All the cells grew in a similar fashion, and production of biotin was found to increase with cell growth. There was no difference in the cells transformed with pET16b/BioB when compared with those that were producing His6-tagged protein indicating that the tag does not seem to affect the activity of wild-type biotin synthase. Similar experiments were carried out with the five mutant plasmids, all the clones grew as vigorously to those of the wild-type, but only the non-conserved C288T mutant produced significant amounts of biotin. Cells expressing the C53S, C57S, C60S, or C188S mutants did not produce any detectable quantities of biotin (Table V).
|
| |
DISCUSSION |
|---|
|
|
|---|
Biotin synthase has two dimeric forms that contain different types
of [Fe-S] clusters. In its oxidized form the protein contains a
single [2Fe-2S] cluster in each monomer unit, but on reduction this
converts to a single [4Fe-4S] cluster in the dimer. EPR and Raman
spectroscopy studies have provided evidence that in the oxidized
[2Fe-2S] form biotin synthase has one Fe3+ that is
coordinated to two cysteines and one Fe3+ that is
coordinated to a cysteine and an oxygenic ligand (21, 22). In contrast,
after dithionite reduction a [4Fe-4S] cluster is formed in which each
iron is coordinated to a single cysteine sulfur. A possible mechanism
for this interconversion has been proposed by Johnson et al.
(22) (Fig. 3). It has been speculated that the cysteine residues of the highly conserved "cysteine box" GXCXXXCXXCXQ motif of these
proteins are involved in [Fe-S] cluster binding. This is supported by
the fact that an identical motif is found in other [Fe-S] cluster
proteins such as LIPA (Swiss-Prot accession number P25845) (19), ARR-AE
(P39329) (32), LAM (33), the nitrogen fixation B gene product (P11067) (34), pyrrolo-quinoline-quinone synthase (Q01060) (35), PFL-AE (P09374)
(17), NARA protein (P39757) (36), FNR (P03019) (37), benzylsuccinate
synthase-activating enzyme (CAA05050) (38), spore photoproduct lyase
(P37956) (39), molybdenum cofactor synthase (O27593) (40), and the
thiamine synthase H gene product (P30140) (39). Mutational studies on
PFL-AE have shown that the three cysteine residues of the cysteine box
are vital for its activity (41).
|
Our attempts to purify wild-type biotin synthase from overexpressing clones using previously reported methods afforded protein that was ~90% pure contaminated with several high molecular weight contaminants. To circumvent this problem we elected to clone the bioB gene with an N-terminal His6 tag and to purify the fusion using nickel-bound affinity chromatography. This appeared to be a safe approach since E. coli biotin synthase has a relatively long N-terminal sequence, which is either not present or unconserved in the ORFs of genes from other species, and the tag was unlikely to affect enzymatic activity.
A further significant result was that the activity of the N terminus His6-tagged biotin synthase proved indistinguishable from that of the wild-type protein. The His6 tag allows purification of much larger quantities of homogeneous E. coli biotin synthase than previously available. Typically, protein of >95% homogeneity can be isolated in a single chromatographic operation.
Metal analyses on both the wild-type and the His6-tagged protein revealed that they contained the same amount of iron as that reported by Marquet and co-workers (14) but less than that reported by Sanyal et al. (20). This is possibly a result of the high protein expression levels. Shortage of free intracellular Fe2+ and/or the fact that the enzyme involved in cluster formation in the cell is expressed at wild-type levels would lead to a proportion of the biotin synthase population being formed with incomplete clusters. In order to increase the iron content of biotin synthase, the apo-enzyme was prepared anaerobically by treatment of the proteins with sodium dithionite and EDTA, and the [2Fe-2S] cluster was reconstituted by incubation with FeCl3 and Na2S. Although the concentration of biotin synthase with intact [2Fe-2S] clusters was significantly increased by this procedure, both forms produced equal amounts of biotin (0.2 mol biotin/mol protein/h) which is in agreement with reported values (8, 12, 20). This suggests that there is sufficient iron and sulfide in the assay mixture to reconstitute the cluster in situ. Clearly, biotin synthase is not acting as a true catalyst, and one reasonable explanation for this is that an unknown cofactor(s) (possible sulfur donor) is missing from the reaction mixture.
Sequence similarity searches reveal that there at least 20 known
species of bacteria, yeasts, and plants that contain a bioB gene sequence similar to that from E. coli. To date, biotin
synthase from Bacillus sphaericus (42), Arabidopsis
thaliana (43), Saccharomyces cerevisiae (44), and
E. coli (20) have been cloned, overexpressed, and purified.
Sufficient complementation analysis has been carried out on
Methylobacillus, Bacillus flavum (45),
Bacillus subtilis (46), Erwinia herbicola (47),
and Serratia marcescens (48) to confirm that they also
express active biotin synthases. Sequence alignment reveals a number of
conserved regions (Fig. 4). There are 25 completely conserved residues, four of which are cysteine. Three of
these (Cys-53, Cys-57, and Cys-60) lie in the 15-residue cysteine box
motif (K(S/T)GXCXE(D/N)CX(Y/F)CXQS), and the fourth (Cys-188 in the E. coli sequence) is
remote.
|
To determine which of the cysteine residues are involved in stabilizing the [2Fe-2S] and [4Fe-4S] forms of biotin synthase, single point mutations were made of all five cysteine residues (Cys-53, Cys-57, Cys-60, Cys-188, and Cys-288) to either serine or threonine. The choice of cysteine substitution by hydroxylated residues was made to preserve as much as possible the H-bonding character and the side chain geometry of the original cysteine residues. All the mutant proteins were expressed as His6 tag fusions and purified using IMAC. The molecular weights of all the polypeptides were verified by mass spectrometry (Table I), and the purified proteins were characterized by UV-visible spectrophotometry (Fig. 2), nickel, iron, and sulfur analyses (Tables II and III), and in vivo and in vitro assays for biotin production (Tables IV and V).
Native biotin synthase, His6-tagged biotin synthase, and the His6-tagged non-conserved mutant C288T all had similar UV-visible spectrophotometric characteristics that were indicative of intact [2Fe-2S] cluster formation. All of these proteins, along with their apo-proteins and reconstituted holo-proteins, were active both in vitro (Table IV) and in vivo (Table V). In contrast, C53S, C57S, and C60S were all colorless, and their absorption spectra showed no indication of the presence of [2Fe-2S] clusters (Fig. 2) indicating that these residues are absolutely vital for [Fe-S] cluster formation which is in turn crucial for activity. C188S proved to be insoluble and could only be characterized in vivo. The fact that only three cysteine residues appear to be needed for [2Fe-2S] cluster binding (22) and that the C53S, C57S, and C60S mutants are inactive suggest that Cys-188 may be required for correct folding of the protein. Attempts to induce [Fe-S] cluster formation by incubation of these mutants with excess reagents did not result in any significant increase of iron binding.
The only cysteine mutant of E. coli biotin synthase that was catalytically active and could support formation of a [2Fe-2S] cluster was C288S, the mutant of the non-conserved cysteine residue, showing that the presence of C288 is not essential for folding, [2Fe-2S] and [4Fe-4S] cluster formation, or for activity. In contrast, all the conserved residues Cys-53, Cys-57, and Cys-60 of the cysteine box are proven to be absolutely crucial for both the formation of the [2Fe-2S] cluster and the activity of the enzyme. These results are consistent with recent mutational studies on PFL-AE where it was also found that mutations of cysteine residues in the cysteine box abolish metal binding (41).
In the absence of crystallographic evidence, this work is a step toward
the definition of the essential protein residues involved in the
mechanism of [Fe-S] cluster formation in biotin synthase and the
relevance of these to the catalytic action of the enzyme. The inference
of spectroscopic studies on E. coli biotin synthase is that
a hydroxylated residue is also involved in the initial [2Fe-2S]
cluster formation (22) and here the conserved cysteine box residues
Thr-50 and Ser-63 are obvious candidates. Another region in the protein
that is completely conserved is the sequence Tyr-150, Asn-151, His-152,
Asn-153, and Leu-154 which is also found in lipoic acid synthase (13)
(see Fig. 4). Biotin synthase mutants at sites within these sequences
are the subject of current studies. We have recently described the
overexpression, purification, and redox characteristics of the
flavoprotein components of the E. coli biotin synthase
system, FLD, and FLDR (49) and the fact that it is now possible to
obtain relatively large quantities of these, and functional,
homogeneous BioB protein should facilitate examination of
the protein-protein and protein-cofactor interactions involved in the
redox chemistry of the biotin synthase complex.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. S. P. Webster and Dr. L. Jiang for mass spectrometry; N. Preston for DNA sequencing; and Dr. M. Fuhrmann (Lonza AG) for pB030.
| |
Addendum |
|---|
Since the acceptance of this manuscript Hewitson et al. (Hewitson, K. S., Baldwin, J. E., Shaw, N. M., and Roach, P. L. (2000) FEBS Lett. 466, 372-376) have published the results of a similar study on E. coli biotin synthase. They describe the characterization of three biotin synthase mutant enzymes C53A, C57A, and C60A. All three mutant enzymes were inactive in in vitro dethiobiotin to biotin conversion assays but are reported to exhibit the characteristic UV-visible spectrum of a [2Fe-2S]2+ cluster, in contrast to the C53S, C57S, and C60S mutants described here. The exact nature of these differences awaits further structural investigation and highlights the complexity of the biotin synthase system.
| |
FOOTNOTES |
|---|
* This work was supported in part by the Biotechnology and Biological Sciences Research Council (BBSRC).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequences reported in this paper have been submitted to the Swiss Protein Database under Swiss-Prot accession numbers P12996, O67104, P54967, P19206, P53557, P46396, Q9Z6L5, Q47862, P44987, O25956, P94966, P46715, O06601, P32451, O60050, P36569, and P73538.
Supported by the Department of Chemistry, Edinburgh University.
§ To whom correspondence should be addressed. Tel.: 44 131 650 4712; Fax: 44 131 650 7155; E-mail: Dominic.Campopiano@ed.ac.uk (for D. J. C.) or Tel.: 44 131 650 4708; Fax: 44 131 650 7155; E-mail: r.baxter@ed.ac.uk (for R. L. B.).
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
AdoMet, S-adenosylmethionine;
CV, column volume;
DTT, dithiothreitol;
FLD, E. coli Flavodoxin;
FLDR, E.
coli flavodoxin (ferredoxin) NADP+ oxidoreductase;
His6, six consecutive histidine residues;
ICP-AES, inductively coupled plasma-atomic emission spectroscopy;
IMAC, immobilized metal affinity chromatography;
IPTG, isopropyl-
,D-thiogalactopyranoside;
LAM, lysine
2,3-aminomutase;
LIPA, lipoic acid synthase;
PFL-AE, pyruvate formate
lyase-activating enzyme;
ARR-AE, ribonucleotide reductase-activating
enzyme;
PAGE, polyacrylamide gel electrophoresis;
Bis-Tris, 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol;
PCR, polymerase chain reaction.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Otsuka, A.,
Buonocristiani, M. R.,
Howard, P. K.,
Flamm, J.,
Johnson, C.,
Yamomoto, R.,
Uchida, K.,
Cook, C.,
Ruppert, J.,
and Matzuki, J.
(1988)
J. Biol. Chem.
263,
19577-195785 |
| 2. | Alexeev, D., Alexeeva, M., Baxter, R. L., Campopiano, D. J., Webster, S. P., and Sawyer, L. (1998) J. Mol. Biol. 284, 401-419[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Kack, H., Sandmark, J., Gibson, K., Schneider, G., and Lindqvist, Y. (1999) J. Mol. Biol. 291, 857-876[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Alexeev, D., Bury, S. M., Boys, C. W. G., Sawyer, L., Ramsey, A. J., Baxter, H. C., and Baxter, R. L. (1994) J. Mol. Biol. 235, 774-776[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Sanyal, I., Gibson, K. J., and Flint, D. H. (1996) Arch. Biochem. Biophys. 326, 48-56[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Ifuku, O., Koga, N., Haze, S., Kishimoto, J., and Wachi, Y. (1994) Eur. J. Biochem. 224, 173-178[Medline] [Order article via Infotrieve] |
| 7. |
Birch, O. M.,
Fuhrmann, M.,
and Shaw, N. M.
(1995)
J. Biol. Chem.
270,
19158-19165 |
| 8. | Méjean, A., Tse Sum Bui, B., Florentin, D., Ploux, O., Izumi, Y., and Marquet, A. (1995) Biochem. Biophys. Res. Commun. 217, 1231-1237[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Baxter, R. L., Camp, D. J., Cotts, A., and Shaw, N. (1992) J. Chem. Soc. Perkin Trans. 1, 255-258 |
| 10. | Marti, F. B. (1983) Zur biosynthese von biotin: Einsatz von Vorlaufern mit chiraler Methylgruppe.Ph.D. thesis , Edigenossischem Technischen Hochschule, Zurich |
| 11. | Parry, R. J. (1980) Tetrahedron Lett. 21, 4783-4786[CrossRef] |
| 12. | Guianvarc'h, D., Florentin, D., Tse Sum Bui, B., Nunzi, F., and Marquet, A. (1997) Biochem. Biophys. Res. Commun. 236, 402-406[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Marquet, A., Florentin, D., Ploux, O., and Tse Sum Bui, B. (1998) J. Phys. Org. Chem. 11, 529-535[CrossRef] |
| 14. | Tse Sum Bui, B., Florentin, D., Fournier, F., Ploux, O., Méjean, A., and Marquet, A. (1998) FEBS Lett. 440, 226-230[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Zheng, L., White, R. H., Cash, V., and Dean, D. (1994) Biochemistry 33, 4714-4720[CrossRef][Medline] [Order article via Infotrieve] |
| 16. |
Mulliez, E.,
Fontecave, M.,
Gaillard, J.,
and Reichard, P.
(1993)
J. Biol. Chem.
268,
2296-2299 |
| 17. | Broderick, J. B., Duderstadt, R. E., Fernandez, D. C., Wojtuszewski, K., Henshaw, T. F., and Johnson, M. K. (1997) J. Am. Chem. Soc. 119, 7396-7397[CrossRef] |
| 18. | Leider, K. W., Booker, S., Ruzicka, F. J., Beinert, H., Reed, G. H., and Frey, P. A. (1998) Biochemistry 37, 2578-2585[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Ollangier-de Choudons, S., and Fontecave, M. (1999) FEBS Lett. 453, 25-28[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Sanyal, I., Cohen, G., and Flint, D. H. (1994) Biochemistry 33, 3625-3631[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Duin, E. C., Lafferty, M. E., Crouse, B. R., Allen, R. M., Sanyal, I., Flint, D. H., and Johnson, M. K. (1997) Biochemistry 36, 11811-11820[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Johnson, M. K., Staples, C. R., Duin, E. C., Lafferty, M. E., and Duderstadt, R. E. (1998) Pure Appl. Chem. 70, 939-946 |
| 23. | Begley, T., Xi, J., Kinsland, C., Taylor, S., and McLafferty, F. (1999) Curr. Opin. Chem. Biol. 3, 623-629[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | DeMoll, E., and Shive, W. (1986) Anal. Biochem. 158, 55-58[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Sarker, G., and Sommers, S. S. (1990) BioTechniques 8, 404-407[Medline] [Order article via Infotrieve] |
| 26. | Bradford, M. M. (1976) Anal. Biochem. 72, 248-254[CrossRef][Medline] [Order article via Infotrieve] |
| 27. |
Barton, G. J.
(1993)
Protein Eng.
6,
37-40 |
| 28. | Harris, D. C. (1948) Quantitative Chemical Analysis , pp. 513-532, W. H. Freeman & Co., New York |
| 29. | Stookey, L. L. (1970) Anal. Chem. 42, 779-781[CrossRef] |
| 30. | Tse Sum Bui, B., and Marquet, A. (1997) Methods Enzymol. 279, 356-362[Medline] [Order article via Infotrieve] |
| 31. | Busby, R. W., Schelvis, J. P. M., Yu, D. S., Babcock, G. T., and Marletta, M. A. (1999) J. Am. Chem. Soc. 121, 4706-4707[CrossRef] |
| 32. | Ollangier, S., Meier, C., Mulliez, E., Gaillard, J., Schuenemann, V., Trautwein, A., Mattioloi, T., Lutz, M., and Fontecave, M. (1999) J. Am Chem. Soc. 121, 6344-6350[CrossRef] |
| 33. | Frey, P. A., and Reed, G. H. (1993) Adv. Enzymol. Relat. Areas Mol. Biol. 66, 1-39[Medline] [Order article via Infotrieve] |
| 34. |
Joerger, R. D.,
and Bishop, P. E.
(1988)
J. Bacteriol.
170,
1475-1487 |
| 35. |
Liu, S. T.,
Lee, L. Y.,
Tai, C. Y.,
Hung, C. H.,
Chang, Y. S.,
Wolfram, J. H.,
Rogers, R.,
and Goldstein, A. H.
(1992)
J. Bacteriol.
174,
5814-5819 |
| 36. |
Glaser, P.,
Danchin, A.,
Kunst, F.,
Zuber, P.,
and Nakano, M.
(1995)
J. Bacteriol.
177,
1112-1115 |
| 37. |
Shaw, D. J.,
and Guest, J. R.
(1982)
Nucleic Acids Res.
10,
6119-6130 |
| 38. | Leuthner, B., Leutwein, C., Schulz, H., Horth, P., Haehnel, W., Sclitz, E., Schagger, H., and Heider, J. (1998) Mol. Microbiol. 28, 615-628[CrossRef][Medline] [Order article via Infotrieve] |
| 39. |
Fajardo-Cavazos, P.,
Salazar, C.,
and Nicholson, W. L.
(1993)
J. Bacteriol.
175,
1735-1744 |
| 40. |
Smith, D. R.,
Doucette-Stamm, L. A.,
Deloughery, C.,
Lee, H. M.,
Dubois, J.,
Aldredge, T.,
Bashirzadeh, R.,
Blakely, D.,
Cook, R.,
Gilbert, K.,
Harrison, D.,
Hoang, L.,
Keagle, P.,
Lumm, W.,
Pothier, B.,
Qui, D.,
Spadafora, R.,
Vicare, R.,
Wang, Y.,
Weizerbowski, J.,
Gibson, R.,
Jiwani, N.,
Caruso, A.,
Bush, D.,
Safer, H.,
Patwell, D.,
Prabhakar, S.,
McDougall, S.,
Shimer, G.,
Goyal, A.,
Pietrovski, S.,
Church, G. M.,
Daniels, C. J.,
Mao, J. I.,
Rice, P.,
Nolling, J.,
and Reeve, J. N.
(1997)
J. Bacteriol.
179,
7135-7155 |
| 41. |
Kulzer, R.,
Pils, T.,
Kappl, R.,
Huttermann, J.,
and Knappe, J.
(1998)
J. Biol. Chem.
273,
4897-4903 |
| 42. | Florentin, D., Bui, B., Marquet, A., Ohshiro, T., and Izumi, Y. (1994) C. R. Acad. Sci. 317, 485-488 |
| 43. | Baldet, P., Alaban, C., and Douce, R. (1997) FEBS Lett. 419, 206-210[CrossRef][Medline] [Order article via Infotrieve] |
| 44. | Flint, D. H., and Allen, R. M. (1997) Methods Enzymol. 279, 349-356[Medline] [Order article via Infotrieve] |
| 45. | Serebriiskii, I. G., Vassin, V. M., and Tsygankov, Y. D. (1996) Gene (Amst.) 175, 15-22[CrossRef][Medline] [Order article via Infotrieve] |
| 46. |
Bower, S.,
Perkins, J. B.,
Rogers, Y., R,
Howitt, C. L.,
Raiham, P.,
and Pero, J.
(1996)
J. Bacteriol.
178,
4122-4130 |
| 47. | Wu, C. H., Chen, H. Y., and Shiuan, D. (1996) Gene (Amst.) 174, 251-258[CrossRef][Medline] [Order article via Infotrieve] |
| 48. |
Sakurai, N.,
Imai, Y.,
Masuda, M.,
Komatsubara, S.,
and Tosa, T.
(1993)
Appl. Environ. Microbiol.
59,
2857-2863 |
| 49. | McIver, L., Leadbeater, C., Campopiano, D. J., Baxter, R. L., Daff, S. N., Chapman, S. K., and Munro, A. W. (1998) Eur. J. Biochem. 257, 577-585[Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
S. Jergic, K. Ozawa, N. K. Williams, X.-C. Su, D. D. Scott, S. M. Hamdan, J. A. Crowther, G. Otting, and N. E. Dixon The unstructured C-terminus of the {tau} subunit of Escherichia coli DNA polymerase III holoenzyme is the site of interaction with the {alpha} subunit Nucleic Acids Res., May 14, 2007; 35(9): 2813 - 2824. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Picciocchi, R. Douce, and C. Alban The Plant Biotin Synthase Reaction: IDENTIFICATION AND CHARACTERIZATION OF ESSENTIAL MITOCHONDRIAL ACCESSORY PROTEIN COMPONENTS J. Biol. Chem., June 27, 2003; 278(27): 24966 - 24975. [Abstract] [Full Text] [PDF] |
||||
![]() |
|